Phar 7.43(5)(a)(a) Visually inspecting all prescription orders, labels and dispensed product. Phar 7.43(5)(b)(b) Labeling requirements under s. Phar 7.05. The prescription label shall contain the name and address of the remote dispensing site as the licensed facility from which the prescribed drug or device was dispensed. Phar 7.43(6)(6) Responsibilities of managing pharmacist. The managing pharmacist responsible for the remote dispensing pharmacy shall do all of the following: Phar 7.43(6)(a)(a) Have written policies and procedures for system operation, safety, security, accuracy and access. Phar 7.43(6)(b)(b) Implement an ongoing quality assurance program that monitors performance that includes the number of prescriptions dispensed per month, number of medication errors documented, loss or diversion, and documentation of remedial training to prevent future errors. Phar 7.43(6)(c)(c) Visit the remote dispensing location at least monthly to confirm delivery status of all drugs, to ensure written policies and procedures are being followed, and to ensure that remote dispensing personnel comply with all federal and state laws regulating the practice of pharmacy. Phar 7.43(6)(d)(d) Retain documentation of the visits at the remote dispensing location for a minimum of 5 years. Phar 7.43(6)(e)(e) Documentation indicating accepting responsibility for compliance with this section, signed and dated by the managing pharmacist. Phar 7.43(7)(7) Delegate requirements. A person engaged in the practice of pharmacy under s. 450.03 (1) (f) or (g), Stats., a pharmacy technician registered under s. 450.068, Stats., or a pharmacy graduate as defined in s. Phar 1.02 (10m) shall meet the following requirements to remote dispense: Phar 7.43(7)(c)(c) Have completed 1500 hours of work as a pharmacist delegate within the 3 years prior to engaging in remote dispensing or completed an accredited pharmacy technician training program. Phar 7.43 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21; correction in (2), (4) (a) 1. made under s. 35.17, Stats., Register December 2020 No. 780; EmR2213: emerg. r. (1), am. (2), (4) (b), (5) (b), (6) (title), (a) (intro.), 5., (b), eff. 11-1-22; CR 23-054: r. (1), am. (2), r. (3), am. (4) (a) 2. (intro.), (b), r. (4) (d), am. (5) (b), r. and recr. (6), am. (7) (intro.) Register August 2024 No. 824, eff. 9-1-24. Phar 7.50Phar 7.50 Definitions. In this subchapter: Phar 7.50(1)(1) “Chart order” means an order entered on the chart or a medical record of an inpatient or resident of an institutional facility by a practitioner or practitioner’s delegate for a drug product or device. Phar 7.50(2)(2) “Institutional facility” means a facility, as defined in s. 647.01 (4), Stats.; any hospital, nursing home, community-based residential facility, county home, county infirmary, county hospital, county mental health complex, or other place licensed or approved by the department of health services under s. 49.70, 49.71, 49.72, 50.03, 50.032, 50.033, 50.034, 50.35, 51.08, or 51.09, Stats.; a facility under s. 45.50, 51.05, 51.06, 146.903 (1) (b), 233.40, 233.41, 233.42, or 252.10, Stats.; a hospice facility under s. 50.90 (1) (c), Stats.; a county jail; and a correctional facility operated under the authority of the department of corrections. Phar 7.50(3)(3) “Institutional pharmacy” means a pharmacy that provides pharmacy services to an institutional facility. This definition is not for purposes under s. 450.09 (1) (a), Stats. Phar 7.50 HistoryHistory: CR 19-145: cr. Register December 2020 No. 780, eff. 1-1-21. Phar 7.51Phar 7.51 Chart orders. A chart order shall contain all of the following: Phar 7.51(2)(2) Patient’s medical record number or date of birth. Phar 7.51(4)(4) Name, strength, and form of the drug product or device prescribed. Phar 7.51(6)(6) The signature by one of the following methods: Phar 7.51(6)(a)(a) If handwritten, the practitioner’s or delegate’s signature.